Location permission needed for a better experience.
EN
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 1994 Akdeniz Üniversitesi Tıp Fakültesi Kardiyoloji
  • 1991 Akdeniz Üniversitesi Tıp Fakültesi İç Hastalıkları
  • 1983 Ege Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2019 Acıbadem Sağlık Grubu
  • 2012 - 2019 Özel Kadıköy Florence Nightingale Hastanesi
  • 2011 - 2012 Medical Park Hastanesi-Gebze
  • 2011 - 2011 Alman Hastanesi-Çamlıca
  • 2010 - 2011 Medical Park Hastanesi-Göztepe
  • 2001 - 2010 Pamukkale Üniversitesi Tıp Fakültesi / Kardiyoloji Anabilim Dalı
  • 1991 - 2001 Akdeniz Üniversitesi Tıp Fakültesi / Kardiyoloji Anabilim Dalı
  • 1987 - 1991 Akdeniz Üniversitesi Tıp Fakültesi / İç Hastalıkları Anabilim Dalı
  • 1985 - 1987 Ayşekadın Sağlık Ocağı-Edirne / Zorunlu Hizmet
  • 1984 - 1985 GATA / Dermatoloji Anabilim Dalı-Ankara / Askerlik Hizmeti
  • 1983 - 1984 Aşıkzülali Köyü Sağlık Ocağı-Posof-Ardahan / Zorunlu Hizmet
MEMBERSHIPS
  • European Society of Cardiology
  • Türk Tabipleri Birliği
  • European Association of Percutaneous Coronary Intervention
  • Türk Kardiyoloji Derneği
  • Acute Cardiovascular Care Membership of European Society of Cardiology
  • Tromboz, Hemostaz ve Anjioloji Derneği
  • Türk Kardiyoloji Derneği Girişimsel Kardiyoloji Birliği
  • Türk Kardiyoloji Derneği Hipertansiyon Çalışma Grubu
  • Türk Kardiyoloji Derneği Lipid Çalışma Grubu
  • Türk Kardiyoloji Derneği Koroner Kalp Hastalığı Çalışma Grubu
PUBLICATIONS
  • Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension. J Electrocardiol 2012; 45: 123-128 Sengul C, Cevik C, Ozveren O, Oduncu V, Sunbul A, Kılıcarslan F, Semiz E, Dindar I.
  • Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome Echocardiography 2011; 28: 853-858 Sengul C, Cevik C, Ozveren O, Oduncu V, Sunbul A, Akgun T, Can Mm, Semiz E, Dindar I.
  • Acute alcohol consumption is associated with increased interatrial electromechanical delay in healthy men Cardiol J 2011; 18: 682-686 Sengul C, Cevik C, Ozveren O, Sunbul A, Oduncu V, Akgun T, Can Mm, Semiz E, Dindar I.
  • Assessment of atrial conduction time in patients with coronary artery ectasia. Pacing Clin Electrophysiol 2011; 34: 1468-1474 Sengul C, Cevik C, Ozveren O, Sunbul A, Kilicarslan F, Oduncu V, Can M, Semiz E, Dindar I.
  • Relationship between hemorheology and Glu(298)Asp polymorphism of endothelial nitric oxide synthase gene in patients with coronary artery disease Mol Biol Rep 2010; 37: 171-178 Bor-Kucukatay M, Demır S, Akbay R, Dursunoglu D, Akdag B, Semiz E.
  • Decreased plasma adiponectin concentrations in patients with syndrome X Susam I, Yaylalı Yt, Dursunoglu D, Göksoy H, Oztürk M, Yaylalı O, Semiz E. Acta Cardiol 2010; 65: 217-220
  • Body fat distribution in childhood obesity: association with metabolic risk factors Indian Pediatr 2008; 45: 457-462 Semiz S, Özgoren E, Sabir N, Semiz E.
  • Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease? Can J Cardiol 2008; 24: 209-212 Göçmen Ay, Sahin E, Semiz E, Gümuşlü S.
  • Metabolic syndrome in childhood obesity Indian Pediatr 2007; 44: 657-662 Semiz S, Bıcan M, Cakaloz I, Semiz E.
  • Effect of obstructive sleep apnea on aortic elastic parameters: relationship to left ventricular mass and function. Tanrıverdi H, Evrengül H, Kaftan A, Kara Co, Kuru O, Tanrıverdi S, Özkurt S, Semiz E. Circ J 2006; 70: 737-743
  • Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism Circ J 2005; 69: 1105-1110 Tanrıverdi H, Evrengul H, Tanrıverdi S, Turgut S, Akdag B, Kaftan Ha, Semiz E.
  • Assessment of percutaneous coronary intervention on regional and global left ventricular function in patients with chronic total occlusions. Can J Cardiol 2005; 21: 275-280 Ermis C, Boz A, Tholakanahallı V, Yalcınkaya S, Semiz E, Sancaktar O, Benditt DG, Değer N.
  • Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region Eur J Cardiovasc Prev Rehabil 2005; 12: 185-186 Göçmen YA, Semiz E, Gümüşlü S.
  • Association between paraoxonase-1 (PON1) activity and lipid peroxidation indicators levels in people living in Antalya region with angiographically documented coronary artery disease Clin Cardiol 2004; 27: 426-430 Göçmen A.Y., Gümüşlü S., Semiz E.
  • Heart rate variability in patients with rheumatoid arthritis Rheumatol Int 2004; 24:198-202 Evrengül H, Dursunoglu D, Cobankara V, Polat B, Seleci D, Kabukçu S, Kaftan A, Semiz E, Kilic M.
  • Comparison of initial and long-term follow-up of heparin-coated Jostent with conventional NIR stent Jpn Heart J 2003; 44: 889-98 Semiz E., Ermiş C., Yalçınkaya S., Sancaktar O., Değer N.
  • Effect of beta-blockers on QT dispersion and ventricular late potentials in patients with acute myocardial infarction receiving thrombolytic therapy Brief communications of the International Society of Non-Invasive Cardiology. Acta Cardiologica 2003; 58: 3 Evrengül H., Dursunoğlu D., Kayıkçıoğlu M., Can L., Kuru Ö., Kaftan A., Semiz E., Kılıç M.
  • Mechanical complications of intra-aortic balloon counterpulsation Kumbasar SD., Semiz E., Sancaktar O., Yalçınkaya S., Değer N. Int J Cardiol 1999; 70: 69-73
  • Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction Angiology 1999; 50: 465-471 Kumbasar SD., Semiz E., Sancaktar O., Yalçınkaya S., Ermiş C., Değer N.
  • Late results of combined percutaneous balloon valvuloplasty of mitral and tricuspid valves. Sancaktar O., Kumbasar SD., Semiz E., Yalçınkaya S. Cathet Cardiovasc Diagn 1998; 45: 246-250
  • Effect of intraaortic balloon counter-pulsation on QT dispersion in acute anterior myocardial infarction. Int J Cardiol 1998; 65: 169-172 Kumbasar SD., Semiz E., Ermiş C., Yalçınkaya S., Değer N., Pamir G., Oral D.
  • Erythrocyte selenium-glutathione peroxidase activity is lower in patients with coronary atherosclerosis Jpn Heart J 1997; 38: 793-798 Yeğin A., Yeğin H., Alıcıgüzel Y., Değer N., Semiz E.
  • Do multiple stents multiply the risk for restenosis in acute coronary syndromes? Eur Heart J 1997; 18: 484 Ege H., Yalçınkaya S., Semiz E., Sancaktar O., Kumbasar SD., Değer N
  • Comparative clinical and angiographic analysis of the initial efficacy and long-term follow-up of Wiktor stent implantation with conventional balloon angioplasty Jpn Heart J 1997; 38: 625-635 Semiz E., Sancaktar O., Yalçınkaya S., Ege H., Değer N.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP
How can we help you?